Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
8.41
+0.36 (4.41%)
At close: Nov 21, 2024, 4:00 PM
8.48
+0.08 (0.89%)
After-hours: Nov 21, 2024, 4:41 PM EST
Altimmune Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Altimmune stock have an average target of 20, with a low estimate of 12 and a high estimate of 26. The average target predicts an increase of 137.95% from the current stock price of 8.41.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Altimmune stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +42.77% | Nov 14, 2024 |
| UBS | UBS | Strong Buy Initiates $26 | Strong Buy | Initiates | $26 | +209.34% | Nov 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +42.77% | Aug 22, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +137.95% | Aug 12, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +137.95% | Jun 25, 2024 |
Financial Forecast
Revenue This Year
6.06K
from 426.00K
Decreased by -98.58%
Revenue Next Year
n/a
from 6.06K
EPS This Year
-1.40
from -1.66
EPS Next Year
-1.49
from -1.40
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 21,000 | n/a | n/a | ||
| Avg | 6,060 | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -95.1% | - | - | ||
| Avg | -98.6% | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.31 | -1.22 | -1.26 | ||
| Avg | -1.40 | -1.49 | -1.60 | ||
| Low | -1.49 | -1.93 | -2.13 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.